DURHAM, N.C. & SEATTLE-- November 13, 2023--Pioneering epigenome editing company Tune Therapeutics has announced it is working on a new and potentially curative approach to treating chronic HBV infection. The...
VCs Invest $23M In Roche Holding Spinout Afferent Pharmaceuticals
News | 12. 16. 2009
Afferent Pharmaceuticals
Venture firms are investing $23 million to spin out a start-up from Roche Holding Ltd. that plans to attack chronic pain in a new way.
